NFL Biosciences SA (EPA: ALNFL)

NFL Biosciences Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Dec 31, 2021	Dec 31, 2021	Dec 31, 2020
Other Revenue	0	0	0
Revenue	0	0	0
Revenue Growth (YoY)	-	1200.00%	-
Cost of Revenue	0.53	0.53	0.17
Gross Profit	-0.53	-0.53	-0.17
Selling, General & Admin	0.28	0.28	0.11
Other Operating Expenses	0.05	0.05	0
Operating Expenses	0.37	0.37	0.15
Operating Income	-0.9	-0.9	-0.32
Interest Expense	-0	-0	-
Interest & Investment Income	0	0	-
Other Non Operating Income (Expenses)	-0.22	-0.22	-
EBT Excluding Unusual Items	-1.12	-1.12	-0.32
Other Unusual Items	-	-	0
Pretax Income	-1.12	-1.12	-0.31
Income Tax Expense	-0.14	-0.14	-0.05
Net Income	-0.98	-0.98	-0.26
Net Income to Common	-0.98	-0.98	-0.26
Shares Outstanding (Basic)	5	5	-
Shares Outstanding (Diluted)	5	5	-
EPS (Basic)	-0.19	-0.19	-
EPS (Diluted)	-0.19	-0.19	-
Operating Margin	-2312479.49%	-2312479.49%	-10600933.33%
Profit Margin	-2508315.38%	-2508315.38%	-8716666.67%
EBITDA	-0.86	-0.86	-0.28
D&A For EBITDA	0.04	0.04	0.04
EBIT	-0.9	-0.9	-0.32
Revenue as Reported	0	0	0

Source: S&P Capital IQ. Standard template. Financial Sources.